{'fraction_non_alphanumeric': 0.035075653370013754, 'fraction_numerical': 0.039202200825309494, 'mean_word_length': 5.087866108786611, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Profile of Brazilian climacteric women: results from the Brazilian Menopause Study

Abstract Objective This study aims to understand the epidemiological characteristics of Brazilian menopausal women, and their view on menopause hormone therapy (MHT). Methods A national cross-sectional study with 1500 women between 45 and 65 years old was carried out through questionnaires. Results The overall median age of participants was 52 [47–56] years, and 55 [52–59] years for the postmenopausal subgroup. Menstrual irregularity started at median age 46 [44–49] years. Median menopause age was 48 [45–51] years with no differences between socioeconomic classes. The prevalence of any climacteric symptoms was 87.9% and hot flashes started at median age 47 [45–50] years. Among women in menopause/menopausal transition, 52.1% received any medical prescription, and MHT was recommended for 22.3%. Among those who started MHT, 45.4% were still using the treatment and the median duration of use was 8 months, but different among socioeconomic classes (24 months for class A against 3 months for class D/E). Conclusions In this first Brazilian national population-based study on menopause and MHT, it was observed that, in spite of being symptomatic when entering menopause around 48 years of age, only a small part of Brazilian women started MHT and the median duration of treatment was less than 1 year, but the duration was higher for higher socioeconomic class.